Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$332K Buy
3,658
+128
+4% +$11.7K 0.09% 184
2026
Q1
$362K Sell
3,530
-359
-9% -$40.5K 0.12% 169
2025
Q4
$487K Sell
3,889
-164
-4% -$20.9K 0.16% 138
2025
Q3
$543K Sell
4,053
-148
-4% -$19.4K 0.2% 110
2025
Q2
$571K Sell
4,201
-139
-3% -$18.3K 0.23% 99
2025
Q1
$576K Sell
4,340
-12
-0.3% -$1.53K 0.31% 72
2024
Q4
$492K Buy
4,352
+2
+0% +$231 0.25% 83
2024
Q3
$496K Buy
4,350
+295
+7% +$32.4K 0.41% 60
2024
Q2
$421K Sell
4,055
-204
-5% -$21.6K 0.27% 76
2024
Q1
$484K Buy
4,259
+113
+3% +$13K 0.54% 56
2023
Q4
$456K Buy
+4,146
New +$414K 0.58% 51

Other funds holding ABT

Sunpointe's ABT Position: Q2 2026 in Review

Sunpointe increased its Abbott (ABT) stake by 3.6% in Q2 2026, buying an estimated $11.7K and bringing the position to 3,658 shares worth $332K. The position accounts for 0.09% of the portfolio, ranked #184.

Sunpointe first reported a position in ABT in Q4 2023 and has held it in 11 quarters since. The position peaked at $576K in Q1 2025. 2,968 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Sunpointe held 3,658 shares of Abbott worth $332K as of Q2 2026.
  • Sunpointe bought 128 Abbott shares in Q2 2026, an estimated $11.7K.
  • Abbott made up 0.09% of Sunpointe's portfolio in Q2 2026, its #184 holding.
  • Sunpointe first reported a position in Abbott in Q4 2023 and has held it in 11 quarters since.
  • Sunpointe's Abbott position peaked at $576K in Q1 2025.
  • 2,968 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Sunpointe's 13F filing for Q2 2026, filed 24 Jul 2026.